Hyllengren Eric J 4
4 · Atara Biotherapeutics, Inc. · Filed Aug 20, 2024
Insider Transaction Report
Form 4
Hyllengren Eric J
EVP, CFO and COO
Transactions
- Sale
Common Stock
2024-08-16$6.63/sh−1,041$6,901→ 24,785 total - Sale
Common Stock
2024-08-16$6.63/sh−29$192→ 24,756 total
Footnotes (3)
- [F1]Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2024 and August 19, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.
- [F3]This amount reflects the 1:25 reverse stock split effected by the Issuer on June 20, 2024.